Mirta Varela

8.7k total citations
10 papers, 307 citations indexed

About

Mirta Varela is a scholar working on Oncology, Immunology and Allergy and Genetics. According to data from OpenAlex, Mirta Varela has authored 10 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Immunology and Allergy and 2 papers in Genetics. Recurrent topics in Mirta Varela's work include Cell Adhesion Molecules Research (3 papers), Glioma Diagnosis and Treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). Mirta Varela is often cited by papers focused on Cell Adhesion Molecules Research (3 papers), Glioma Diagnosis and Treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). Mirta Varela collaborates with scholars based in Argentina, Peru and Brazil. Mirta Varela's co-authors include Lydia Puricelli, José Lastiri, Marı́a Guadalupe Pallotta, Elisa Bal de Kier Joffé, Stella Maris Ranuncolo, Eugenia Sacerdote de Lustig, Laura B. Todaro, Ana Morandi, Virginia Ladeda and Silvia Christiansen and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Neurobiology of Disease.

In The Last Decade

Mirta Varela

10 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mirta Varela Argentina	8	138	93	87	83	43	10	307
Juergen Kiwit Germany	7	145 1.1×	101 1.1×	92 1.1×	183 2.2×	22 0.5×	8	580
Sridhar Reddy Chirasani Germany	7	212 1.5×	142 1.5×	137 1.6×	203 2.4×	47 1.1×	7	593
Wenliang Li China	12	259 1.9×	88 0.9×	103 1.2×	98 1.2×	62 1.4×	27	423
Aneta Kwiatkowska United States	8	248 1.8×	115 1.2×	109 1.3×	146 1.8×	64 1.5×	11	502
Huarui Zheng China	8	232 1.7×	125 1.3×	104 1.2×	117 1.4×	59 1.4×	17	501
Arend H. Sikkema Netherlands	9	196 1.4×	50 0.5×	32 0.4×	39 0.5×	37 0.9×	12	340
Sophie Guelfi France	8	157 1.1×	90 1.0×	79 0.9×	74 0.9×	23 0.5×	10	317
D. Marković Germany	6	191 1.4×	154 1.7×	143 1.6×	282 3.4×	25 0.6×	11	684
Ruifan Xie China	11	189 1.4×	99 1.1×	85 1.0×	131 1.6×	30 0.7×	19	372
Jessica Tomé-García United States	10	178 1.3×	60 0.6×	100 1.1×	104 1.3×	44 1.0×	17	342

Countries citing papers authored by Mirta Varela

Since Specialization

Citations

This map shows the geographic impact of Mirta Varela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirta Varela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirta Varela more than expected).

Fields of papers citing papers by Mirta Varela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirta Varela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirta Varela. The network helps show where Mirta Varela may publish in the future.

Co-authorship network of co-authors of Mirta Varela

This figure shows the co-authorship network connecting the top 25 collaborators of Mirta Varela. A scholar is included among the top collaborators of Mirta Varela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirta Varela. Mirta Varela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Gómez, Henry, Silvia P. Neciosup, C. Tosello, et al.. (2015). A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). Clinical Breast Cancer. 16(1). 38–44. 19 indexed citations

Marshall, John L., Dale E. Shuster, Terri Goldberg, et al.. (2014). A randomized, open-label phase II study of efatutazone in combination with FOLFIRI as second-line therapy for metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 32(3_suppl). 535–535. 4 indexed citations

Todaro, Laura B., Silvia Christiansen, Mirta Varela, et al.. (2007). Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors. Journal of Neuro-Oncology. 83(2). 135–144. 35 indexed citations

Ranuncolo, Stella Maris, Mirta Varela, Ana Morandi, et al.. (2004). Prognostic Value of Mdm2, p53 and p16 in Patients with Astrocytomas. Journal of Neuro-Oncology. 68(2). 113–121. 27 indexed citations

Todaro, Laura B., Lydia Puricelli, Marı́a Guadalupe Pallotta, et al.. (2004). Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type. Neurobiology of Disease. 15(2). 387–393. 48 indexed citations

Varela, Mirta, Stella Maris Ranuncolo, José Lastiri, et al.. (2004). EGF‐R and PDGF‐R, but not bcl‐2, overexpression predict overall survival in patients with low‐grade astrocytomas. Journal of Surgical Oncology. 86(1). 34–40. 57 indexed citations

Lastiri, José, et al.. (2002). [Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer].. PubMed. 62(1). 41–7. 7 indexed citations

Ranuncolo, Stella Maris, Virginia Ladeda, Ana Morandi, et al.. (2002). Expression of CD44s and CD44 splice variants in human melanoma. Oncology Reports. 9(1). 51–6. 16 indexed citations

Ranuncolo, Stella Maris, Virginia Ladeda, Mirta Varela, et al.. (2001). CD44 expression in human gliomas. Journal of Surgical Oncology. 79(1). 30–36. 52 indexed citations

10.

Farias, Eduardo, et al.. (2000). Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. International Journal of Cancer. 89(4). 389–394. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact